Hospital-Acquired Infection Control Market Growth Trajectory Through 2024-2033

The Hospital-Acquired Infection Control Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Hospital-Acquired Infection Control Market:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

According to The Business Research Company’s Hospital-Acquired Infection Control Global Market Report 2024, The hospital-acquired infection control market size has grown steadily in recent years. It will grow from $33.01 billion in 2023 to $34.35 billion in 2024 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing antibiotic resistance, growing awareness, stringent regulations, globalization of infectious diseases, patient safety initiatives.

The hospital-acquired infection control market size is expected to see steady growth in the next few years. It will grow to $41.37 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, international collaboration. Major trends in the forecast period include adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, shift towards single-use and disposable devices, emphasis on staff training and education, increased utilization of disinfection technologies.

The surge in COVID-19 cases is expected to propel the growth of the hospital-acquired infection control market going forward. COVID-19 refers to a viral infection that is caused by the SARS-CoV-2 virus. Due to the COVID-19 pandemic, there is an increase in demand for hospital-acquired infection control products and services to focus on personal hygiene and the production of infection control medical supplies. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, as of 8th August 2022, the global COVID-19 cases reached 581.6 million. Therefore, the surge in COVID-19 cases is driving the growth of the hospital-acquired infection control market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

The hospital-acquired infection control market covered in this report is segmented – 

1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users

Major companies operating in the hospital-acquired infection control market are developing innovative products such as digital platform to increase their profitability in the market. A digital platform in hospital-acquired infection control refers to an integrated and technology-driven solution designed to manage, monitor, and enhance infection prevention and control measures within healthcare facilities. For instance, in June 2021, Nanosonics, an Australia based healthcare technology provider launched AuditPro. AuditPro is a cutting-edge infection prevention platform for medical settings, specializing in ultrasound procedures. It includes a mobile scanning device, a user-friendly app for decision support, real-time risk alerts, and information-packed dashboards. The system has two tailored solutions, organizations can select the AuditPro Digital Logbook or Workflow Compliance Management Solution for flexible digital traceability, seamlessly integrating with the trophon2 device for comprehensive infection prevention.

The hospital-acquired infection control market report table of contents includes:

1. Executive Summary
2.Hospital-Acquired Infection Control Market Characteristics
3.Hospital-Acquired Infection Control Market Trends And Strategies
4. Hospital-Acquired Infection ControL market analysis
5.Hospital-Acquired Infection Control Market Size And Growth
6. Hospital-Acquired Infection ControlSegmentation
7.Hospital-Acquired Infection Control Regional And Country Analysis
.
.
.
27.Hospital-Acquired Infection Control Competitive Landscape And Company Profiles
28.Hospital-Acquired Infection Control Key Mergers And Acquisitions
29.Hospital-Acquired Infection Control Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Johnson and Johnson
• P&G Professional
• Honeywell International Inc.
• MMM Group
• 3M Company

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model